Lilly has a website for improving turnaround time for biomarkers in lung cancer. Find it here:
The webpage leads to a one-page infographic PDF and also to a one minute video.
For limited samples, consider an additional biopsy pass, and flag usable blocks in the path report.
For delayed ordering, use education and/or reflex or algorithmic testing.
For extended analysis time, consolidate testing.
For lack of provider integration, consider patient navigaters, improved record-keeping, and enhanced EMR technologies.
